Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci
Lara E. Sucheston‐Campbell(The Ohio State University), Christine B. Ambrosone(Unknown), G. Thomas Budd(Cleveland Clinic), Song Yao(Roswell Park Comprehensive Cancer Center), Kouros Owzar(Duke University), Daniel O. Stram, Xin Sheng(University of Southern California), Deanna L. Kroetz(University of California, San Francisco), Jule R. Gralow(Seattle Cancer Care Alliance), Gary Zirpoli(Roswell Park Comprehensive Cancer Center), Kathy S. Albain(Loyola University Chicago), Christopher A. Haiman(University of Southern California), Alyssa Clay‐Gilmour(University of South Carolina), Daniel F. Hayes(University of Michigan–Ann Arbor), Claudine Isaacs(Georgetown University), Timothy J. Hobday(Mayo Clinic), William E. Barlow(Cancer Research And Biostatistics), Dawn L. Hershman(Columbia University), Li Yan(Sanford Burnham Prebys Medical Discovery Institute), Chen Jiang, Abbas Rizvi(Tempus Labs (United States)), James A. Stewart(University of Mississippi), Muhammad Salim(Saskatchewan Cancer Agency), Halle C. F. Moore(Cleveland Clinic), Robert B. Livingston(Active Medicine (United Kingdom)), Gabriel N. Hortobágyi(The University of Texas MD Anderson Cancer Center)
Cited by 37
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k